Cipla launches RT-PCR test kit ‘ViraGen’ in India, partnership with Ubio Biotech
The Hindu
ViraGen is Cipla’s third offering in the COVID-19 testing segment.
Drug major Cipla on Thursday announced the commercialisation of its RT-PCR test kit ‘ViraGen’ for in India, in partnership with Ubio Biotechnology Systems. “This launch will help address the current testing services and capacity issues while reaffirming the company’s ongoing expansion in the diagnostic space,” Cipla said in a regulatory filing. Cipla will launch ViraGen test kit in the country in partnership with Ubio Biotechnology Systems, the company stated.More Related News